• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Wright Medical gains on Q4 earnings beat

Wright Medical gains on Q4 earnings beat

February 24, 2016 By Brad Perriello

Wright Medical Q3 tops rev, misses earningsWright Medical (NSDQ:WMGI) shares gained today after the orthopedics maker smashed Wall Street’s earnings forecast by a full 25¢ in the 1st quarter since its $3.3 billion merger with Tornier.

Memphis-based Wright posted losses of -$105.8 million, or -90¢ per share from continuing operations, on sales of $177.0 million for the 3 months ended Dec. 27, 2015, cutting losses by -4.9% on sales growth of 112.5% compared with Q4 2014.

Adjusted to exclude 1-time items, losses per share were -8¢, 25¢ better than the consensus estimate on The Street.

Full-year losses were up 15.0% to -$289.7 million, or -$3.68 per share from continuing operations, on sales of $415.5 million, marking a 39.4% top-line gain. Adjusted EPS were -93¢, well below The Street’s -$1.60 forecast.

Wright and Tornier closed their merger in October 2015.

“In our 1st quarter as a newly merged Wright Medical, we delivered outstanding 4th-quarter results that reflect the continued strong underlying growth and positive momentum in our legacy Wright lower extremities and legacy Tornier upper extremities businesses,” president & CEO Robert Palmisano said in prepared remarks. “Our pro forma global extremities and biologics growth of 14% was a 2-percentage-point acceleration from the 3rd quarter of 2015, and combined with earlier-than-anticipated progress on capturing cost synergies, resulted in pro forma net sales and positive adjusted EBITDA results that significantly exceeded our expectations. We also got off to a strong start on executing our merger integration plans and with the early success we are seeing, we believe we are well positioned to continue our strong business momentum and to deliver on our synergy commitments as we progress through 2016.”

Wright said it expects to post adjusted losses of -65¢ to -71¢ on constant-currency sales of $695 million to $705 million.

“Our 2016 guidance assumes mid-teens underlying combined pro forma constant currency growth in extremities and biologics, excluding the impact of anticipated revenue dis-synergies. We also expect growth to accelerate in our biologics business due to the ongoing launch of Augment bone graft in the U.S. We will continue to focus on successfully executing our integration plans to realize our full potential and believe that the positive progress we saw in the 4th quarter is setting us up well for continued strong revenue growth and significant margin expansion in 2016 and beyond,” Palmisano said.

WMGI shares were up 4.0% to $17.83 apiece today in early afternoon trading.

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, Orthopedics Tagged With: wrightmedical

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy